使用机器学习进行增强的药物分类,并进行多重心脏收缩性检测
Reza Aghavali1, Erin G Roberts1, Yosuke K Kurokawa1
1Novoheart, Medera Inc., 6 Tide St., Boston, MA 02210, USA.
Pharmacological research
|October 13, 2024
概括
来自人类干细胞的工程心脏组织改善了药物安全性测试. 这种新模型以86.2%的准确度预测药物心脏毒性,增强临床前药物开发和临床试验的成功.
科学领域:
- 生物医学工程 生物医学工程
- 心血管药理学心血管药理学
- 干细胞生物学 干细胞生物学
背景情况:
- 药物诱导的心脏毒性是临床试验失败的主要原因之一.
- 目前的临床前模型无法充分预测人类的心脏反应.
- 人类多能干细胞衍生的心肌细胞为心脏安全性评估提供了一个有希望的替代方案.
研究的目的:
- 开发和验证一种工程心脏组织模型,用于预测药物心脏毒性.
- 创建一个强大的电子生理学和收缩性反应对已知的化合物的数据集.
- 建立一个集成算法来分类未知的化合物的机械作用.
主要方法:
- 使用了三种不同的工程心脏组织分析.
- 组织暴露于5种机械学类化合物的度增加.
- 开发了一个整体算法,整合了来自六个个别模型的数据.
主要成果:
- 创建了关于心脏电生理学和收缩性的综合数据集.
- 整体算法在分类复合机械作用时实现了86.2%的预测准确度.
- 超越了单个试验模型的预测.
结论:
- 工程心脏组织为人类心脏反应提供了更具预测性的临床前模型.
- 整体算法提高了药物安全查的准确性.
- 这种方法与监管方面的进步保持一致,例如FDA现代化法案2.0以提高药物开发成功率.
更多相关视频
10:39Automated Contraction Analysis of Human Engineered Heart Tissue for Cardiac Drug Safety Screening
Published on: April 15, 2017
12.7K
08:03Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation
Published on: October 20, 2022
1.7K
相关概念视频
01:26Heart Failure Drugs: Inotropic Agents
534
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
534
01:30Cardiomyopathy II: Dilated Cardiomyopathy
1
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
1